Early research (Phase 1)WithdrawnNCT00214214
What this trial is testing
A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
Who this might be right for
New Onset Type 1 Diabetes Mellitus
University of Wisconsin, Madison